Price Alert

Entrada Therapeutics Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

5.29

0.04 (0.76%)

At close: Aug 15, 2025, 3:59 PM

5.27

-0.28%

After-hours: Aug 15, 2025, 04:10 PM EDT

0.76% (1D)

Bid	3.85
Market Cap	201.03M
Revenue (ttm)	79.48M
Net Income (ttm)	-73.35M
EPS (ttm)	-2.03
PE Ratio (ttm)	-2.6
Forward PE	-1.18
Analyst	Buy

Ask	6.69
Volume	186,826
Avg. Volume (20D)	175,343
Open	5.33
Previous Close	5.25
Day's Range	5.21 - 5.36
52-Week Range	4.93 - 21.79
Beta	-0.13

About TRDA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol TRDA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TRDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Entrada Therapeutics has released their quartely earnings on Aug 6, 2025:

Revenue of $1.95M misses estimates by $6.5M, with -97.94% YoY decline.

EPS of -1.04 misses estimates by -0.18, with -167.10% YoY decline.

Next Earnings Release

Entrada Therapeutics Inc. is scheduled to release its earnings on Nov 4, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

News

1 week ago · zacks.com

Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) came out with a quarterly loss of $1.04 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to earnings of $1.55 per share a year ago.

2 weeks ago · zacks.com

Entrada Therapeutics (TRDA) Soars 5.6%: Is Further Upside Left in the Stock?

Entrada Therapeutics (TRDA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price...